Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kailash Ahirwar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Epigenomics|July 15, 2016
Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanismsSabbir Khan, Kailash Ahirwar, Gopabandhu Jena
Journal of Biomaterials Science. Polymer Edition|September 15, 2025
Advancements in cartilage tissue regeneration: harnessing nano- and microtechnology for enhanced mesenchymal stem cells delivery in osteoarthritis treatmentAyush Rohila, Kailash Ahirwar, Rahul Shukla
AAPS Pharmscitech|November 9, 2023
ApoE3 Anchored Liposomal Delivery of Rivastigmine for Brain Delivery: Formulation, Characterization, and In Vivo Pharmacokinetic EvaluationPooja Khairnar, Ajit Singh, Kailash Ahirwar, et al.
Mitochondrion|November 6, 2024
Scientific investigation of non-coding RNAs in mitochondrial epigenetic and aging disorders: Current nanoengineered approaches for their therapeutic improvementVaibhav Patange, Kailash Ahirwar, Tripti Tripathi, et al.
Molecular Neurobiology|April 1, 2024
Receptor-Assisted Nanotherapeutics for Overcoming the Blood-Brain BarrierAkshada Mhaske, Shalini Shukla, Kailash Ahirwar, et al.
International Journal of Biological Macromolecules|March 24, 2024
Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunitiesKailash Ahirwar, Ankit Kumar, Nidhi Srivastava, et al.
Drug Discovery Today|November 23, 2024
Nondestructive techniques for pharmaceutical drug product characterizationSarwar Beg, Kailash Ahirwar, Waleed H Almalki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 17, 2024
Trans-nasal brain delivery of anti-TB drugs by methyl-β-cyclodextrin microparticles show efficient mycobacterial clearance from central nervous systemKrishna Jadhav, Agrim Jhilta, Raghuraj Singh, et al.
PNAS Nexus|January 30, 2023
Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areataJerry Tsai, Sadakatali Gori, Jesse Alt, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Epigenomics|July 15, 2016
Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanismsSabbir Khan, Kailash Ahirwar, Gopabandhu Jena
Journal of Biomaterials Science. Polymer Edition|September 15, 2025
Advancements in cartilage tissue regeneration: harnessing nano- and microtechnology for enhanced mesenchymal stem cells delivery in osteoarthritis treatmentAyush Rohila, Kailash Ahirwar, Rahul Shukla
AAPS Pharmscitech|November 9, 2023
ApoE3 Anchored Liposomal Delivery of Rivastigmine for Brain Delivery: Formulation, Characterization, and In Vivo Pharmacokinetic EvaluationPooja Khairnar, Ajit Singh, Kailash Ahirwar, et al.
Mitochondrion|November 6, 2024
Scientific investigation of non-coding RNAs in mitochondrial epigenetic and aging disorders: Current nanoengineered approaches for their therapeutic improvementVaibhav Patange, Kailash Ahirwar, Tripti Tripathi, et al.
Molecular Neurobiology|April 1, 2024
Receptor-Assisted Nanotherapeutics for Overcoming the Blood-Brain BarrierAkshada Mhaske, Shalini Shukla, Kailash Ahirwar, et al.
International Journal of Biological Macromolecules|March 24, 2024
Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunitiesKailash Ahirwar, Ankit Kumar, Nidhi Srivastava, et al.
Drug Discovery Today|November 23, 2024
Nondestructive techniques for pharmaceutical drug product characterizationSarwar Beg, Kailash Ahirwar, Waleed H Almalki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 17, 2024
Trans-nasal brain delivery of anti-TB drugs by methyl-β-cyclodextrin microparticles show efficient mycobacterial clearance from central nervous systemKrishna Jadhav, Agrim Jhilta, Raghuraj Singh, et al.
PNAS Nexus|January 30, 2023
Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areataJerry Tsai, Sadakatali Gori, Jesse Alt, et al.
Pageof 1